RACHELLE COUGHLIN: Open Payments
NPI 1710424205 · VOORHEES, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$849 in 51 payments from 17 companies in 2025. Trend: 2023 $1,048 · 2024 $859 · 2025 $849
Food & beverage: $849
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 5 | $98 |
| Janssen Biotech, Inc. | 5 | $93 |
| UCB, Inc. | 5 | $90 |
| Novartis Pharmaceuticals Corporation | 5 | $88 |
| E.R. Squibb & Sons, L.L.C. | 5 | $80 |
| Amgen Inc. | 4 | $73 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 4 | $72 |
| GENZYME CORPORATION | 2 | $41 |
| Incyte Corporation | 2 | $36 |
| Botanix SB Inc | 2 | $33 |
Products named: TREMFYA, Bimzelx, COSENTYX, Sotyktu, TALTZ, OTEZLA, ILUMYA, DUPIXENT.
Industry payments across NJ — which companies pay providers there.
